酒精戒断综合征
医学
金标准(测试)
人口
酒精摄入量
干预(咨询)
精神科
重症监护医学
酒
内科学
戒断综合征
麻醉
生物化学
环境卫生
化学
作者
Fabio Attilia,Roberta Perciballi,Claudia Rotondo,Ida Capriglione,Silvia Iannuzzi,Maria Luisa Attilia,Giovanna Coriale,Mario Vitali,Federica Cereatti,Marco Fiore,Mauro Ceccanti
出处
期刊:PubMed
[National Institutes of Health]
日期:2019-01-28
卷期号:53 (3): 118-122
被引量:58
摘要
Alcohol withdrawal syndrome (AWS) is a medical emergency, rare in the general population, but very common among alcoholic individuals, which can lead to severe complications when unrecognized or late treated. It represents a clinical condition which can evolve in few hours or days following an abrupt cessation or reduction of alcohol intake and is characterized by hyperactivity of the autonomic nervous system resulting in the development of typical symptoms. According to DSM-5 criteria, the alcohol withdrawal syndrome is defined as such: if patients present at least two of typical signs and symptoms. The Clinical Institute Withdrawal Assessment of Alcohol Scale, revised version (CIWA-Ar), is the tool for assessing the severity of AWS. The support to patient with AWS includes pharmacological intervention as well as general support, restoration of biochemical imbalances and specific therapy. Regarding the pharmacological treatment, benzodiazepines represent the gold standard, in particular long-acting benzodiazepines, administered with a gradual reduction up to cessation.
科研通智能强力驱动
Strongly Powered by AbleSci AI